{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:03:00Z","timestamp":1773745380168,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54 NS079202"],"award-info":[{"award-number":["U54 NS079202"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tetramethylenedisulfotetramine (TETS), a noncompetitive GABA<jats:sub>A<\/jats:sub> receptor antagonist, is a potent, highly lethal convulsant that is considered to be a chemical threat agent. Here, we assessed the ability of the AMPA receptor antagonist perampanel to protect against TETS-induced seizures and lethality in mice when administered before or after treatment with the toxicant. For comparison, we conducted parallel testing with diazepam, which is a first-line treatment for chemically induced seizures in humans. Pre-treatment of mice with either perampanel (1\u20134\u00a0mg\/kg, i.p.) or diazepam (1\u20135\u00a0mg\/kg, i.p.) conferred protection in a dose-dependent fashion against tonic seizures and lethality following a dose of TETS (0.2\u00a0mg\/kg, i.p.) that rapidly induces seizures and death. The ED<jats:sub>50<\/jats:sub> values for protection against mortality were 1.6\u00a0mg\/kg for perampanel and 2.1\u00a0mg\/kg for diazepam. Clonic seizures were unaffected by perampanel and only prevented in a minority of animals by high-dose diazepam. Neither treatment prevented myoclonic body twitches. Perampanel and diazepam also conferred protection against tonic seizures and lethality when administered 15\u00a0min following a 0.14\u00a0mg\/kg, i.p., dose of TETS and 5\u00a0min following a 0.2\u00a0mg\/kg, i.p., dose of TETS. Both posttreatments were highly potent at reducing tonic seizures and lethality in animals exposed to the lower dose of TETS whereas greater doses of both treatments were required in animals exposed to the larger dose of TETS. Neither treatment was as effective suppressing clonic seizures. In an experiment where 0.4\u00a0mg\/kg TETS was administered by oral gavage and the treatment drugs were administered 5\u00a0min later, perampanel only partially protected against lethality whereas diazepam produced nearly complete protection. We conclude that perampanel and diazepam protect against TETS-induced tonic seizures and lethality but have less impact on clonic seizures. Both drugs could have utility in the treatment of TETS intoxication but neither eliminates all seizure activity.<\/jats:p>","DOI":"10.1007\/s00204-021-03053-9","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T09:04:17Z","timestamp":1619687057000},"page":"2459-2468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam"],"prefix":"10.1007","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-0119","authenticated-orcid":false,"given":"Dorota","family":"Zolkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5746-7312","authenticated-orcid":false,"given":"Ashish","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-8193","authenticated-orcid":false,"given":"Michael A.","family":"Rogawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"3053_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1476-5381.1975.tb07379.x","volume":"53","author":"NG Bowery","year":"1975","unstructured":"Bowery NG, Brown DA, Collins JF (1975) Tetramethylenedisulphotetramine: an inhibitor of \u03b3-aminobutyric acid induced depolarization of the isolated superior cervical ganglion of the rat. Br J Pharmacol 53:422\u2013424","journal-title":"Br J Pharmacol"},{"key":"3053_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuropharm.2015.03.035","volume":"95","author":"DA Bruun","year":"2015","unstructured":"Bruun DA, Cao Z, Inceoglu B, Vito ST, Austin AT, Hulsizer S, Hammock BD, Tancredi DJ, Rogawski MA, Pessah IN, Lein PJ (2015) Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. Neuropharmacology 95:332\u2013342. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.03.035","journal-title":"Neuropharmacology"},{"key":"3053_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.neuint.2012.02.035","volume":"61","author":"L Ceolin","year":"2012","unstructured":"Ceolin L, Bortolotto ZA, Bannister N, Collingridge GL, Lodge D, Volianskis A (2012) A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochem Int 61:517\u2013522","journal-title":"Neurochem Int"},{"issue":"9","key":"3053_CR4","doi-asserted-by":"publisher","first-page":"e108021","DOI":"10.1371\/journal.pone.0108021","volume":"9","author":"CY Chen","year":"2014","unstructured":"Chen CY, Matt L, Hell JW, Rogawski MA (2014) Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons. PLoS ONE 9(9):e108021","journal-title":"PLoS ONE"},{"issue":"1","key":"3053_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/nyas.14479","volume":"1480","author":"A Dhir","year":"2020","unstructured":"Dhir A, Bruun DA, Guignet M, Tsai YH, Gonz\u00e1lez E, Calsbeek J, Vu J, Saito N, Tancredi DJ, Harvey DJ, Lein PJ, Rogawski MA (2020) Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate-induced status epilepticus in rats. Ann N Y Acad Sci. 1480(1):183\u2013206. https:\/\/doi.org\/10.1111\/nyas.14479","journal-title":"Ann N Y Acad Sci."},{"key":"3053_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0028-3908(75)90094-5","volume":"14","author":"A Dray","year":"1975","unstructured":"Dray A (1975) Tetramethylenedisulphotetramine and amino acid inhibition in the rat brain. Neuropharmacology 14:703\u2013705","journal-title":"Neuropharmacology"},{"key":"3053_CR7","unstructured":"Greenfield Jr LJ, Sahaya K, Lee S-H (2021) Benzodiazepines (Chapter 48). In: Wyllie E, editor-in-chief; Gidal BE, Goodkin HP, Jehi L, Loddenkemper T, associate editors. Wyllie\u2019s treatment of epilepsy. Principles and practice. 7th ed. Philadelphia: Wolters Kluwer, p. 575\u2013598"},{"key":"3053_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","volume":"52","author":"T Hanada","year":"2011","unstructured":"Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52:1331\u20131340","journal-title":"Epilepsia"},{"issue":"5","key":"3053_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/prp2.63","volume":"2","author":"T Hanada","year":"2014","unstructured":"Hanada T, Ido K, Kosasa T (2014) Effect of perampanel, a novel AMPA antagonist, on benzodiazepine-resistant status epilepticus in a lithium-pilocarpine rat model. Pharmacol Res Perspect 2(5):1\u20137","journal-title":"Pharmacol Res Perspect"},{"key":"3053_CR10","doi-asserted-by":"publisher","first-page":"104335","DOI":"10.1016\/j.nbd.2018.11.020","volume":"133","author":"DA Jett","year":"2020","unstructured":"Jett DA, Spriggs SM (2020) Translational research on chemical nerve agents. Neurobiol Dis 133:104335. https:\/\/doi.org\/10.1016\/j.nbd.2018.11.020","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3053_CR102","first-page":"1223","volume":"270","author":"TG Kokate","year":"1994","unstructured":"Kokate TG, Svensson BE, Rogawski MA (1994) Anticonvulsant activity of neurosteroids: correlation with \u03b3-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270(3):1223\u20131229","journal-title":"J Pharmacol Exp Ther"},{"key":"3053_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1476-5381.1975.tb07401.x","volume":"53","author":"WA Large","year":"1975","unstructured":"Large WA (1975) Effect of tetramethylenedisulphotetramine on the membrane conductance increase produced by \u03b3-amino-butyric acid at the crab neuromuscular junction. Br J Pharmacol 53:598\u2013599","journal-title":"Br J Pharmacol"},{"key":"3053_CR12","doi-asserted-by":"publisher","first-page":"104491","DOI":"10.1016\/j.nbd.2019.104491","volume":"133","author":"M Laukov\u00e1","year":"2020","unstructured":"Laukov\u00e1 M, Vel\u00ed\u0161kov\u00e1 J, Vel\u00ed\u0161ek L, Shakarjian MP (2020) Tetramethylenedisulfotetramine neurotoxicity: what have we learned in the past 70 years? Neurobiol Dis. 133:104491. https:\/\/doi.org\/10.1016\/j.nbd.2019.104491","journal-title":"Neurobiol Dis."},{"key":"3053_CR13","unstructured":"L\u00f6scher W, Rogawski MA. Epilepsy. (2002) In: Lodge D, Danysz W, Parsons CG, (eds.). Ionotropic glutamate receptors as therapeutic targets. F.P. Graham Publishing Co., Johnson City, pp. 91\u2013132"},{"key":"3053_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuro.2019.08.004","volume":"74","author":"MC Moffett","year":"2019","unstructured":"Moffett MC, Rauscher NA, Rice NC, Myers TM (2019) Survey of drug therapies against acute oral tetramethylenedisulfotetramine poisoning in a rat voluntary consumption model. Neurotoxicology 74:264\u2013271. https:\/\/doi.org\/10.1016\/j.neuro.2019.08.004","journal-title":"Neurotoxicology"},{"key":"3053_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1124\/mol.117.108563","volume":"92","author":"AM Nik","year":"2017","unstructured":"Nik AM, Pressly B, Singh V, Antrobus S, Hulsizer S, Rogawski MA, Wulff H, Pessah IN (2017) Rapid throughput analysis of GABAA receptor subtype modulators and blockers using DiSBAC1(3) membrane potential red dye. Mol Pharmacol 92:88\u201399","journal-title":"Mol Pharmacol"},{"issue":"3","key":"3053_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/toxics6030051","volume":"6","author":"J Patocka","year":"2018","unstructured":"Patocka J, Franca TCC, Wu Q, Kuca K (2018) Tetramethylenedisulfotetramine: a health risk compound and a potential chemical warfare agent. Toxics 6(3):51. https:\/\/doi.org\/10.3390\/toxics6030051","journal-title":"Toxics"},{"issue":"1","key":"3053_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1124\/molpharm.120.000090","volume":"99","author":"B Pressly","year":"2021","unstructured":"Pressly B, Lee RD, Barnych B, Hammock BD, Wulff H (2021) Identification of the functional binding site for the convulsant tetramethylenedisulfotetramine in the pore of the \u03b12\u03b23\u03b32 GABAA receptor. Mol Pharmacol. 99(1):78\u201391. https:\/\/doi.org\/10.1124\/molpharm.120.000090","journal-title":"Mol Pharmacol."},{"key":"3053_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuro.2017.08.009","volume":"63","author":"NC Rice","year":"2017","unstructured":"Rice NC, Rauscher NA, Langston JL, Myers TM (2017) Behavioral intoxication following voluntary oral ingestion of tetramethylenedisulfotetramine: dose-dependent onset, severity, survival, and recovery. Neurotoxicology 63:21\u201332. https:\/\/doi.org\/10.1016\/j.neuro.2017.08.009","journal-title":"Neurotoxicology"},{"key":"3053_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0306-4492(81)90083-6","volume":"70","author":"CJ Roberts","year":"1981","unstructured":"Roberts CJ, James VA, Collins JF, Walker RJ (1981) The action of seven convulsants as antagonists of the GABA response of Limulus neurons. Comp Biochem Physiol C 70:91\u201396","journal-title":"Comp Biochem Physiol C"},{"key":"3053_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ane.12099","volume":"197","author":"MA Rogawski","year":"2013","unstructured":"Rogawski MA (2013) AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl 197:9\u201318. https:\/\/doi.org\/10.1111\/ane.12099","journal-title":"Acta Neurol Scand Suppl"},{"key":"3053_CR21","unstructured":"Rogawski MA (2017) Perampanel. In: Pellock JM, Nordli DR, Sankar R, Wheless JW (eds.). Pediatric Epilepsy, 4th Edition. Demos Medical"},{"key":"3053_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ane.12100","volume":"197","author":"MA Rogawski","year":"2013","unstructured":"Rogawski MA, Hanada T (2013) Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand Suppl 197:19\u201324","journal-title":"Acta Neurol Scand Suppl"},{"issue":"1","key":"3053_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.taap.2012.08.037","volume":"265","author":"MP Shakarjian","year":"2012","unstructured":"Shakarjian MP, Vel\u00ed\u0161kov\u00e1 J, Stanton PK, Vel\u00ed\u0161ek L (2012) Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABAA receptors. Toxicol Appl Pharmacol 265(1):113\u2013121","journal-title":"Toxicol Appl Pharmacol"},{"key":"3053_CR101","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuro.2015.03.007","volume":"48","author":"MP Shakarjian","year":"2015","unstructured":"Shakarjian MP, Ali MS, Vel\u00ed\u0161kov\u00e1 J, Stanton PK, Heck DE, Vel\u00ed\u0161ek L (2015) Combined diazepam and MK-801 therapy provides synergistic protection from tetramethylenedisulfotetramine-induced tonic-clonic seizures and lethality in mice. Neurotoxicology 48:100\u2013108. https:\/\/doi.org\/10.1016\/j.neuro.2015.03.007","journal-title":"Neurotoxicology"},{"issue":"4","key":"3053_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1528-1157.1982.tb05426.x","volume":"23","author":"AK Shenoy","year":"1982","unstructured":"Shenoy AK, Miyahara JT, Swinyard EA, Kupferberg HJ (1982) Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital, and valproate in mice and rats. Epilepsia 23(4):399\u2013408","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"3053_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/epi.12493","volume":"55","author":"BJ Steinhoff","year":"2014","unstructured":"Steinhoff BJ (2014) Efficacy of perampanel: a review of pooled data. Epilepsia 55(Suppl 1):9\u201312. https:\/\/doi.org\/10.1111\/epi.12493","journal-title":"Epilepsia"},{"issue":"3","key":"3053_CR26","first-page":"369","volume":"151","author":"EA Swinyard","year":"1966","unstructured":"Swinyard EA, Castellion AW (1966) Anticonvulsant properties of some benzodiazepines. J Pharmacol Exp Ther 151(3):369\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"3053_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuropharm.2015.03.014","volume":"95","author":"F Twele","year":"2015","unstructured":"Twele F, Bankstahl M, Klein S, R\u00f6mermann K, L\u00f6scher W (2015) The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. Neuropharmacology 95:234\u2013242. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.03.014","journal-title":"Neuropharmacology"},{"issue":"2","key":"3053_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.taap.2014.10.001","volume":"281","author":"ST Vito","year":"2014","unstructured":"Vito ST, Austin AT, Banks CN, Inceoglu B, Bruun DA, Zolkowska D, Tancredi DJ, Rogawski MA, Hammock BD, Lein PJ (2014) Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. Toxicol Appl Pharmacol. 281(2):185\u2013194. https:\/\/doi.org\/10.1016\/j.taap.2014.10.001","journal-title":"Toxicol Appl Pharmacol."},{"issue":"3","key":"3053_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0920-1211(93)90054-B","volume":"15","author":"S Yamaguchi","year":"1993","unstructured":"Yamaguchi S, Donevan SD, Rogawski MA (1993) Anticonvulsant activity of AMPA\/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res 15(3):179\u2013184","journal-title":"Epilepsy Res"},{"issue":"2","key":"3053_CR100","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1124\/jpet.111.190579","volume":"341","author":"D Zolkowska","year":"2012","unstructured":"Zolkowska D, Banks CN, Dhir A, Inceoglu B, Sanborn JR, McCoy MR, Bruun DA, Hammock BD, Lein PJ, Rogawski MA (2012) Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J Pharmacol Exp Ther 341(2):435\u2013446. https:\/\/doi.org\/10.1124\/jpet.111.190579","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"3053_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1124\/jpet.114.212779","volume":"351","author":"R Zwart","year":"2014","unstructured":"Zwart R, Sher E, Ping X, Jin X, Sims JR Jr, Chappell AS, Gleason SD, Hahn PJ, Gardinier K, Gernert DL, Hobbs J, Smith JL, Valli SN, Witkin JM (2014) Perampanel, an antagonist of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models. J Pharmacol Exp Ther 351(1):124\u2013133","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03053-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-021-03053-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03053-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T18:03:02Z","timestamp":1624989782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-021-03053-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3053"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-03053-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal experiments were conducted under a protocol approved by the University of California, Davis Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}